Genenta-Backed Sòphia High Tech Reports Strong FY 2025 Revenue Growth

Key Facts

1Sòphia High Tech sales rose 29.3% to €7.17 million for the fiscal year 2025.

2The company's operating profit advanced 80.8% to €1.21 million.

3Genenta Science is evolving into Saentra Forge, an industrial consolidator focused on defense and national security.

Reflecting a strategic pivot toward defense and national security sectors, Sòphia High Tech, backed by Genenta Science, reported robust financial results for the fiscal year 2025. According to reports, the company's sales increased by 29.3% to reach €7.17 million, while operating profit surged by 80.8% to €1.21 million. This performance coincides with Genenta Science's evolution into Saentra Forge, an industrial consolidator specifically focused on defense and national security interests.

The significant growth in both revenue and operating profit underscores the success of the company's strategic shift into aerospace, defense, and biotech sectors. These results indicate a substantial improvement in EBITDA margins, strengthening the firm's position within its new industrial consolidation framework. This growth was achieved despite a broader slowdown in regional manufacturing, as market data showed European industrial production fell by 0.2% in mid-July.

Regarding market performance, GNTA shares stood at $1.65 at the close of July 21, 2026, having traded between a low of $1.52 and a high of $1.67 during the session. Investors are now looking for the continued execution of the Saentra Forge strategy in the national security space. While the upcoming economic calendar shows no immediate catalysts for the stock, the focus remains on the long-term integration of its industrial defense assets.